Psychiatry · White Plains, NY
NPI
1356348536
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
60 Greenridge Ave
White Plains, NY, 10605
Phone (914) 948-3904
Medicare paid, 2024
$309K
4,422 services
Medicare patients, 2024
298
Average age 85
Drug cost, 2024
$1.3M
4,924 prescriptions
Company payments, 2025
$23K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlo Bayrakdarian was code 90833 (psychotherapy - nongroup), 2,037 times for 234 patients. In total Carlo Bayrakdarian billed 4,422 services in 12 codes, and Medicare paid $309K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90833 Psychotherapy - Nongroup | Office | 2,037 | 234 | $57.00 | $116K |
| 99213 Office E&M - Established | Office | 1,167 | 178 | $74.27 | $87K |
| 99214 Office E&M - Established | Office | 530 | 175 | $105.21 | $56K |
| 99212 Office E&M - Established | Office | 390 | 107 | $46.22 | $18K |
| 99348 Home E&M - New and Established | Office | 112 | 13 | $60.07 | $6,727 |
| 99205 Office E&M - New | Office | 105 | 105 | $174.16 | $18K |
| 99204 Office E&M - New | Office | 30 | 30 | $138.70 | $4,161 |
By year: 2022 $275K for 2,359 services; 2023 $325K for 4,378 services; 2024 $309K for 4,422 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlo Bayrakdarian prescribed most often to Medicare patients was Memantine Hcl Er (Memantine Hcl), with 836 prescriptions and refills. In total Carlo Bayrakdarian wrote 4,924 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Er Memantine Hcl | 836 | 850 | 105 | $68K |
| Mirtazapine Generic | 502 | 507 | 67 | $11K |
| Rivastigmine Generic | 457 | 467 | 79 | $61K |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 386 | 396 | 52 | $23K |
| Memantine Hcl Generic | 339 | 339 | 50 | $14K |
| Rexulti Brexpiprazole | 201 | 201 | 34 | $278K |
| Donepezil Hcl Generic | 191 | 191 | 32 | $3,276 |
| Quetiapine Fumarate Generic | 180 | 182 | 31 | $2,838 |
| Trazodone Hcl Generic | 174 | 182 | 29 | $2,231 |
| Vraylar Cariprazine Hcl | 146 | 148 | 28 | $208K |
| Olanzapine Generic | 132 | 132 | 22 | $2,022 |
| Quetiapine Fumarate Er Quetiapine Fumarate | 121 | 121 | 21 | $5,497 |
| Sertraline Hcl Generic | 97 | 101 | 18 | $2,166 |
| Escitalopram Oxalate Generic | 97 | 97 | 14 | $936 |
| Vilazodone Hcl Generic | 75 | 79 | 12 | $8,050 |
Brand drugs: 706 claims; generic drugs: 4,218 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlo Bayrakdarian $23K ($23K in general payments such as food, travel and fees) from 11 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 28 | $12K |
| Axsome Therapeutics, Inc. AXSM | 31 | $6,948 |
| Abbvie Inc. ABBV | 25 | $1,157 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $858 |
| Lilly USA, LLC LLY | 5 | $621 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $419 |
| Janssen Pharmaceuticals, Inc JNJ | 3 | $416 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $372 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 2 | $170 |
| Grifols USA, LLC | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.